`Mediterranean Diet with Olive Oil Shown to Modulate Gut Bacteria, Improve Insulin Sensitivity and Metabolic Syndrome - Olive Oil Times

Mediterranean Diet with Olive Oil Shown to Modulate Gut Bacteria, Improve Insulin Sensitivity and Metabolic Syndrome

Feb. 29, 2016
Jedha Dening

Recent News

The human body is host to tril­lions of gut bac­te­ria, also known as micro­biome, that col­lec­tively con­trol many of the bod­ies func­tions includ­ing the immune sys­tem and energy bal­ance. It has now become appar­ent that a cer­tain bal­ance of gut bac­te­ria is opti­mal for human health. In fact, an asso­ci­a­tion has been made to dys­lipi­demia, insulin resis­tance and type 2 dia­betes when an indi­vid­ual devel­ops an imbal­ance in the gut bac­te­ria. It is thought that the changes in bac­te­r­ial diver­sity can pro­mote inflam­ma­tion, insulin resis­tance and meta­bolic syn­drome.

It has been well estab­lished that dietary inter­ven­tions can change the bac­te­r­ial diver­sity and pro­vide a ther­a­peu­tic tool for treat­ing con­di­tions that may be influ­enced by gut bac­te­ria. Two recent stud­ies have explored how the Mediterranean diet (MedDiet) with olive oil influ­ences gut bac­te­ria, insulin sen­si­tiv­ity and meta­bolic syn­drome.

Long-term con­sump­tion of the Med and LFHCC diets exerts a pro­tec­tive effect on the devel­op­ment of type 2 dia­betes by dif­fer­ent spe­cific changes in the gut micro­biota.- Researchers

The first study, pub­lished last month in the Journal of Clinical Endocrinology and Metabolism, was con­ducted over a period of one year in 20 obese par­tic­i­pants within the Coronary Diet Intervention With Olive Oil and Cardiovascular Prevention (CORDIOPREV) study.

The study com­pared a MedDiet (35 per­cent fat, 22 per­cent monoun­sat­u­rated) to a low-fat, high com­plex car­bo­hy­drate (LFHCC) diet (28 per­cent fat, 12 per­cent monoun­sat­u­rated) to changes in bac­te­r­ial diver­sity related to insulin sen­si­tiv­ity and type 2 dia­betes. The main fat source for the MedDiet group was olive oil, the research team dis­trib­ut­ing olive oil to all par­tic­i­pants to ensure this was the case.

Both diets showed changes in bac­te­r­ial diver­sity, but in dif­fer­ent ways. The authors say­ing: Our results sug­gest that long-term con­sump­tion of the Med and LFHCC diets exerts a pro­tec­tive effect on the devel­op­ment of type 2 dia­betes by dif­fer­ent spe­cific changes in the gut micro­biota, increas­ing the abun­dance of the Roseburia genus and F. praus­nitzii, respec­tively.”


The role of gut bac­te­ria, and the large diver­sity of their nature means this is a fairly com­plex area that is not yet fully under­stood. However, a study pub­lished in PLoS ONE, 2013, sug­gests that Roseburia and F. praus­nitzii are both buryrate-pro­duc­ing bac­te­ria, that also sup­ply other short chain fatty acids that help reduce oxida­tive stress and inflam­ma­tion.

A sec­ond study, also con­ducted within the CORDIOPREV study, pub­lished last month in the Journal of Nutritional Biochemistry, fol­lowed 239 par­tic­i­pants: 138 par­tic­i­pants with meta­bolic syn­drome and 101 par­tic­i­pants with­out.

At base­line there were notice­able dif­fer­ences in the gut bac­te­ria of both groups. The rel­a­tive abun­dance of Bacteroides, Eubacterium and Lactobacillus gen­era was higher in the par­tic­i­pants with meta­bolic syn­drome. The rel­a­tive abun­dance of 18 other bac­te­r­ial species were lower in the par­tic­i­pants with meta­bolic syn­drome at base­line.

To assess whether the dietary inter­ven­tions had impact on the bac­te­r­ial pro­file, the bac­te­ria were exam­ined again after 2 years. In the MedDiet group the abun­dance of P. dis­ta­so­nis, B. thetaio­taomi­cron, F. praus­nitzii, B. ado­les­cen­tis and B. longum were sig­nif­i­cantly increased in those with meta­bolic syn­drome but not in those with­out. On the other hand, the abun­dance of E. rec­tale increased and P. dis­an­so­nis decreased in the non-meta­bolic syn­drome group only.

This study revealed that despite the meta­bolic syn­drome still being present in par­tic­i­pants, sig­nif­i­cant changes to gut bac­te­ria do occur. Most notably, the gut bac­te­ria that improved in abun­dance in the meta­bolic syn­drome group show a neg­a­tive cor­re­la­tion with lev­els of glu­cose, triglyc­erides, and HDL cho­les­terol, sup­port­ing the idea that gut bac­te­ria can indeed influ­ence insulin resis­tance and the devel­op­ment of meta­bolic syn­drome, whereas these changes did not occur in the non-meta­bolic syn­drome group.

Researchers sug­gest that it is a com­bi­na­tion of fiber and the phe­no­lic-com­pound-rich foods such as olive oil, veg­eta­bles, fruits, wine and so forth, that con­tribute to these pos­i­tive changes in gut bac­te­ria.

Since it is now well estab­lished that meta­bolic syn­drome is asso­ci­ated with chronic low-grade inflam­ma­tion, another impor­tant obser­va­tion was that the con­sump­tion of a Mediterranean diet increased the abun­dance of the Bacteroides genus mem­ber B. thetaio­taomi­cron and F. praus­nitzii, which sug­gest that the con­sump­tion of this diet may increase or main­tain a micro­biota with anti-inflam­ma­tory capa­bil­ity.”


Related Articles

Feedback / Suggestions